N-ACETYLATOR VARIABILITY IN DOWNS-SYNDROME - CHARACTERIZATION WITH CAFFEINE

被引：6

作者：

MORRIS, ME

GRIENER, JC

MSALL, ME

机构：

[1] BUFFALO CHILDRENS HOSP,BUFFALO,NY

[2] SUNY BUFFALO,DEPT PEDIAT,BUFFALO,NY 14260

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 46卷 / 03期

关键词：

D O I：

10.1038/clpt.1989.151

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：359 / 366

页数：8

共 41 条

[1]

BLATT J, 1986, LANCET, V2, P914

[2] CAFFEINE DISPOSITION AFTER ORAL DOSES [J].

BONATI, M ;

LATINI, R ;

GALLETTI, F ;

YOUNG, JF ;

TOGNONI, G ;

GARATTINI, S .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :98-106

[3]

CALLAHAN MM, 1983, DRUG METAB DISPOS, V11, P211

[4]

CARTWRIGHT RA, 1982, LANCET, V2, P842

[5]

CHAPMAN MJ, 1966, J MENT DEFIC RES, V10, P19

[6] KINETIC DISCRIMINATION OF 3 SULFAMETHAZINE ACETYLATION PHENOTYPES [J].

CHAPRON, DJ ;

KRAMER, PA ;

MERCIK, SA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) :104-113

[7] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J].

CLARK, DWJ .

DRUGS, 1985, 29 (04) :342-375

[8] CLEARANCE OF URIC ACID UREA AND CREATININE IN DOWNS SYNDROME [J].

COBURN, SP ;

SEIDENBE.M ;

MERTZ, ET .

JOURNAL OF APPLIED PHYSIOLOGY, 1967, 23 (04) :579-&

[9]

COLEMAN M, 1974, CLIN GENET, V5, P312

[10]

DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P251

← 1 2 3 4 5 →